ISSN 0970-7700
 
2020, Vol: 26, Issue: 2
26 / 2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

1. JREIM Covering Letter and Authors Declaration Form (Section 1-5) Ver. Jan 2021
2. TITLE page - Abstract - References etc-Sections -1 to 6 (NEW 2020-21)
3.JREIM Proforma for Authors CV and Declaration cum Consent Form-Ver-R -151022
4. JREIM Template for Submitting Manuscript in JREIM

Case Report
Online Published: 17 Sep 2019
 


MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT

Sudha Singh; Piyush Krantikumar Gandhi; Deepak Sahebrao Khawale.


Abstract
Background-Ataxia telangiectasia (AT) is a rare autosomal recessive neurocutaneous disorder characterised by progressive neurodegeneration, immunodeficiency, susceptibility to cancer and sensitivity to the ionizing radiation.It manifests in early childhood as telangiectasia, small cluster of dilated vessels on skin and conjunctiva followed by ataxia,trouble in coordinating movement.As per Ayurveda, AT is considered as sannipatik condition with vata and pitta dominance along with decrease in kapha dosha at mamsa and majja dhatu level.Material and Method-this is a case study of 14 years old male child presented with progressive gait difficulties, immunological and ocular manifestations.Observation and Result-This study has shown promising results.It raises hopes that ayurvedic approach can deliver result in similar kind of disorders.

Key words: Ataxia telangiectasia (AT),apraxia, alpha fetoprotein, panchkarma ,truncal ataxia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sudha Singh; Piyush Krantikumar Gandhi; Deepak Sahebrao Khawale
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Singh S, Gandhi PK, Khawale DS. MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT. J Res Educ Indian Med . Online First: 17 Sep, 2019. doi:10.5455/JREIM.82-1540918180

Web Style

Singh S, Gandhi PK, Khawale DS. MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT. https://www.jreim-ayushjournal.com/?mno=15037 [Access: September 12, 2024]. doi:10.5455/JREIM.82-1540918180

AMA (American Medical Association) Style

Singh S, Gandhi PK, Khawale DS. MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT. J Res Educ Indian Med . Online First: 17 Sep, 2019. doi:10.5455/JREIM.82-1540918180


Vancouver/ICMJE Style

Singh S, Gandhi PK, Khawale DS. MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT. J Res Educ Indian Med , [cited September 12, 2024]; Online First: 17 Sep, 2019. doi:10.5455/JREIM.82-1540918180


Harvard Style

Singh, S., Gandhi, . P. K. & Khawale, . D. S. (0) MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT. J Res Educ Indian Med , Online First: 17 Sep, 2019. doi:10.5455/JREIM.82-1540918180


Turabian Style

Singh, Sudha, Piyush Krantikumar Gandhi, and Deepak Sahebrao Khawale. 0. MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT. Journal of Research and Education in Indian Medicine, Online First: 17 Sep, 2019. doi:10.5455/JREIM.82-1540918180


Chicago Style

Singh, Sudha, Piyush Krantikumar Gandhi, and Deepak Sahebrao Khawale. "MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT." Journal of Research and Education in Indian Medicine Online First: 17 Sep, 2019. doi:10.5455/JREIM.82-1540918180


MLA (The Modern Language Association) Style

Singh, Sudha, Piyush Krantikumar Gandhi, and Deepak Sahebrao Khawale. "MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT." Journal of Research and Education in Indian Medicine Online First: 17 Sep, 2019. Web. 12 Sep 2024 doi:10.5455/JREIM.82-1540918180


APA (American Psychological Association) Style

Singh, S., Gandhi, . P. K. & Khawale, . D. S. (0) MANAGEMENT OF ATAXIA TELANGIECTASIA THROUGH AYURVEDA: A CASE REPORT. Journal of Research and Education in Indian Medicine, Online First: 17 Sep, 2019. doi:10.5455/JREIM.82-1540918180


Author LoginReviewer LoginAbout PublisherEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPrivacy PolicyAdvertising PolicyLicense InformationCopyright Information

About Journal of Research and Education in Indian Medicine

The Journal of Research & Education in Indian Medicine (JREIM) is a quarterly peer-reviewed international journal. JREIM has been established and laun ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Websites
http://www.jreim-ayushjournal.com  and  
​http://www.ejmanager.com/my/jreim 
 

JREIM Head Office
B 29/19 Lanka, PO: BHU, Varanasi-221005 UP (India)   
e-mail:  jreim@ejmanager.com,
Tel: (+91) 9305180763

 

If you need to contact an editor, please use the contact details below:
e-mail: editor@jreim-ayushjournal.com, drlaxmi_ayush_journal@yahoo.com
Tel.: (+91) 9305180763 during office hours (10 AM to 5 PM, Monday to Friday)

Rana Gopal Singh, MD, DM
Editor-in- Chief, Integrative Medicine
 rgsingh@bhu.ac.in, profrgsingh@yahoo.com,  

Suresh Kumar, MD (Ayurveda), PhD
Editor-in- Chief, Ayurveda and Yoga
editor-in-chief@jreim-ayushjournal.com,  prof.suresh.india@gmail.com

Change of Address:
To change address or update your personal information, kindly visit your account (author/reviewer/editor) at http://www.ejmanager.com/my/jreim and update your profile.

If you have further queries, we would be happy to answer those. Please send
your queries to  manager@jreim-ayushjournal.com  or call us on +91 9305180763. 

------------------------

Medical advice:
JREIM (http://www.jreim-ayushjournal.com) does not give medical advice and will not be able to respond to inquiries about specific diseases, medical or surgical conditions, diagnosis, treatments or contact of another person.

Authors Contact:
To contact a author, use the information provided with the manuscript; JREIM will not be able to provide additional details.